Mark J Foley Insider Trading $RVNC Revance Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark J Foley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark J Foley. Mark J Foley is in GLAUKOS Corp ($GKOS) and Director in GLAUKOS Corp ($GKOS) and Director in Zeltiq Aesthetics Inc ($ZLTQ) and Interim CEO in Zeltiq Aesthetics Inc ($ZLTQ) and President and CEO in Zeltiq Aesthetics Inc ($ZLTQ) and in SI-BONE, Inc. ($SIBN) and CEO & President in Revance Therapeutics, Inc. ($RVNC) and Director in Revance Therapeutics, Inc. ($RVNC).
Mark J Foley in Revance Therapeutics, Inc.
Trading Symbol: RVNCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Foley: CEO & President, Director
Holdings: 810,279 shares
Current Value: $16,772,775
Latest Transaction: Feb 04 2021
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark J Foley in Revance Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GKOS, RVNC, SIBN, ZLTQ
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2021 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Option Exercise | A | 28.01 | 73,665 | 2,063,357 | 73,665 | |
Feb 04 2021 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 40,715 | 0 | 810,279 | 769.6 K to 810.3 K (+5.29 %) |
Oct 15 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Payment of Exercise | F | 27.62 | 66,106 | 1,825,848 | 769,564 | 835.7 K to 769.6 K (-7.91 %) |
Oct 15 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 50,913 | 0 | 70,913 | 20 K to 70.9 K (+254.57 %) |
Oct 15 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 264,439 | 0 | 835,670 | 571.2 K to 835.7 K (+46.29 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Payment of Exercise | F | 25.14 | 143,269 | 3,601,783 | 571,231 | 714.5 K to 571.2 K (-20.05 %) |
Oct 02 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 301,000 | 0 | 714,500 | 413.5 K to 714.5 K (+72.79 %) |
Jan 24 2020 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 200,000 | 0 | 413,500 | 213.5 K to 413.5 K (+93.68 %) |
Oct 15 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Option Exercise | A | 12.18 | 740,000 | 9,013,200 | 740,000 | |
Oct 15 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 200,000 | 0 | 213,500 | 13.5 K to 213.5 K (+1,481.48 %) |
Oct 15 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Option Exercise | A | 12.18 | 740,000 | 9,013,200 | 740,000 | |
Oct 15 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | CEO & President | Grant | A | 0.00 | 200,000 | 0 | 213,500 | 13.5 K to 213.5 K (+1,481.48 %) |
May 10 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Option Exercise | A | 12.82 | 9,000 | 115,380 | 18,000 | |
May 10 2019 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Grant | A | 0.00 | 4,500 | 0 | 13,500 | 9 K to 13.5 K (+50.00 %) |
May 11 2018 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Option Exercise | A | 29.15 | 6,000 | 174,900 | 6,000 | |
May 11 2018 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Grant | A | 0.00 | 3,000 | 0 | 9,000 | 6 K to 9 K (+50.00 %) |
Nov 09 2017 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Buy | P | 27.45 | 500 | 13,725 | 20,000 | 19.5 K to 20 K (+2.56 %) |
Nov 09 2017 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Buy | P | 26.95 | 19,500 | 525,443 | 19,500 | 0 to 19.5 K |
Sep 07 2017 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Option Exercise | A | 24.55 | 12,000 | 294,600 | 12,000 | |
Sep 07 2017 | RVNC | Revance Therapeuti ... | Foley Mark J | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Page: 1